New from PubMed:
Researchers at San Orsola-Lampighi Hospital in Bologna, Italy studied the safety and effectiveness of eperisone hydrochloride as a muscle relaxant for the treatment of muscle contracture and chronic low back pain. 100 patients with moderate to severe, acute, or relapsing low back pain were treated with 100mg of eperisone 3 times a day for 10 consecutive days. They were assess for spontaneous pain, pain on movement, resistance to passive movement, antalgic rigidity, and tolerability. The treatment consistently was successful as acting as an analgesic and muscle relaxant. Spontaneous pain and pain on movement were significantly decreased. Patients experienced a lower rigidity of the lower back and improved motility. Adverse effects were rare and included light-headedness, occasional vertigo, mild somnolence, and epigastric pain. In most cases the adverse reaction resolved spontaneously and treatment continued. Researchers concluded that eperisone hydrochloride is an effective and safe alternative to traditional analgesics and muscle relaxants for the treatment of chronic low back pain. They note that while rheumatologists traditionally combine a prescription for a muscle relaxant with a pain killer, eperisone treats low back pain on its own. It also exhibited an improved tolerability profile as compared to NSAIDs.
Read the full abstract on PubMed
News Categories Arthritis Autoimmunity BioPharm Business Bones Consumer News Imaging Pain Procedures Skin Spondyloarthropathies
Meeting Highlights
ISEMIR 2009: Video coverage of the Meeting
Miami, March 27, 2009
Miami, March 27, 2009
RWCS 2009: Video coverage of the Symposium
Maui, January 14-17, 2009
Maui, January 14-17, 2009
ACR 2008: News from the Annual Scientific Meeting
San Francisco, October 24-29, 2008
San Francisco, October 24-29, 2008
EULAR 2008: Coverage of the Congress
Paris, June 11-14, 2008
Paris, June 11-14, 2008
ISEMIR 2008: Video coverage of the Meeting
Chicago, April 10, 2008
Chicago, April 10, 2008
AAOS 2008: News from the Annual Meeting
San Francisco, March 5-9, 2008
San Francisco, March 5-9, 2008
News Categories:
Arthritis | Autoimmunity | BioPharm Business | Bones | Imaging | Procedures | Skin | Spondyloarthropathies
Events:
ACR 2007 | ASBMR 2007 | EULAR 2007 | GARN 2007 | LUPUS 2007 | EULAR 2006 | ACR 2006 | ORS 2006 | OARSI 2006
CME:
Publications:
About Us: